Allstate Corporation’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-20,043
Closed -$666K 621
2022
Q2
$666K Sell
20,043
-2,675
-12% -$114K 0.02% 434
2022
Q1
$1.64M Buy
22,718
+1,277
+6% +$92K 0.04% 295
2021
Q4
$1.97M Buy
+21,441
New +$2.56M 0.04% 398
2021
Q2
Sell
-1,193
Closed -$217K 742
2021
Q1
$217K Sell
1,193
-403
-25% -$93.5K 0.01% 705
2020
Q4
$319K Buy
1,596
+627
+65% +$127K 0.01% 604
2020
Q3
$212K Buy
+969
New +$205K 0.01% 637

Other funds holding TDOC

Allstate Corporation's TDOC Position: Q3 2022 in Review

Allstate Corporation sold out of Teladoc Health (TDOC) in Q3 2022, closing a stake of 20,043 shares — an estimated $666K sold.

Allstate Corporation first reported a position in TDOC in Q3 2020 and held it in 6 quarters. The position peaked at $1.97M in Q4 2021. 483 funds tracked by Wall St. Rank hold TDOC as of Q3 2022.

  • Allstate Corporation reported no remaining Teladoc Health position as of Q3 2022 after selling out during the quarter.
  • Allstate Corporation sold 20,043 Teladoc Health shares in Q3 2022, an estimated $666K.
  • Allstate Corporation first reported a position in Teladoc Health in Q3 2020 and held it in 6 quarters.
  • Allstate Corporation's Teladoc Health position peaked at $1.97M in Q4 2021.
  • 483 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2022.

Based on Allstate Corporation's 13F filing for Q3 2022, filed 14 Nov 2022.